BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26131815)

  • 1. Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users.
    Sogabe M; Okahisa T; Nakasono M; Fujino Y; Mitsui Y; Takaoka Y; Kimura T; Okamoto K; Muguruma N; Takayama T
    Medicine (Baltimore); 2015 Jul; 94(26):e1047. PubMed ID: 26131815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of gastric mucosal injury severity with platelet function and gastric pH during low-dose aspirin treatment.
    Nishino M; Sugimoto M; Uotani T; Yamade M; Sahara S; Ichikawa H; Sugimoto K; Umemura K; Watanabe H; Miyajima H; Furuta T
    Digestion; 2013; 88(2):79-86. PubMed ID: 23941821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.
    Tamura I; Fujita T; Tsumura H; Morita Y; Yoshida M; Toyonaga T; Hirano S; Inokuchi H; Kutsumi H; Azuma T
    Intern Med; 2010; 49(23):2537-45. PubMed ID: 21139290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of gastroduodenal mucosal injury in asymptomatic patients taking antiplatelet agents in Japan.
    Yamamoto T; Isono A; Ebato T; Mishina Y; Shirasaki Y; Abe K; Hattori K; Ishii T; Kuyama Y
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):722-5. PubMed ID: 19954710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
    Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
    J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.
    Tamura A; Murakami K; Kadota J;
    QJM; 2011 Feb; 104(2):133-9. PubMed ID: 20870780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of gastroduodenal mucosal injuries in aspirin users.
    Thongbai T
    J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
    Chitapanarux T; Lertprasertsuke N; Kongnak A
    Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroduodenal mucosal injury in patients on antiplatelet therapy.
    Yamamoto T; Sanaka M; Nagasawa K; Abe K; Fukami M; Nakayama S; Tsuchiya A; Ishii T; Kuyama Y
    Thromb Res; 2007; 120(4):465-9. PubMed ID: 17257659
    [No Abstract]   [Full Text] [Related]  

  • 11. Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
    Tseng ZF; Hsu PI; Peng NJ; Kao SS; Tsay FW; Cheng JS; Chen WC; Tsai KF; Tang SY; Chuah SK; Shie CB
    J Chin Med Assoc; 2021 Jan; 84(1):19-24. PubMed ID: 33230059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury.
    Ito Y; Sasaki M; Noguchi S; Yamaguchi S; Okaniwa N; Tanabe A; Noda H; Yanamoto K; Tamura Y; Kondo Y; Masui R; Izawa S; Iida A; Mizuno M; Ogasawara N; Funaki Y; Kasugai K
    United European Gastroenterol J; 2013 Aug; 1(4):259-64. PubMed ID: 24917970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper gastrointestinal mucosal injury associated with ticagrelor plus aspirin, ticagrelor alone, or aspirin alone at 1-year after coronary artery bypass grafting.
    Tang C; Zhu Y; Yang X; Xu B; Ye C; Yang Y; Zhong J; Zhao Q; Yu L
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1720-1730. PubMed ID: 32154936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of gastroduodenal lesions in asymptomatic patients on chronic aspirin or nonsteroidal antiinflammatory drug therapy.
    Jaszewski R
    J Clin Gastroenterol; 1990 Feb; 12(1):10-3. PubMed ID: 2303676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study.
    Hara A; Ota K; Takeuchi T; Kojima Y; Hirata Y; Ozaki H; Kawaguchi S; Takahashi Y; Harada S; Sakanaka T; Ogura T; Nouda S; Kakimoto K; Kawakami K; Asai A; Fukunishi S; Sanomura M; Tominaga K; Higuchi K
    J Clin Biochem Nutr; 2018 Nov; 63(3):224-229. PubMed ID: 30487673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.